Establishing Effective Internal Control Systems to Mitigate Bribery and Corruption Risks
Conducting detailed corporation-wide fraud and corruption risk assessment
Implementation of independent whistleblower or ethics hotlines
Designing and implementing effective anti-bribery and corruption framework
Incorporate anti-corruption procedures into M&As and JV due diligence
Continuous monitoring and proactive responses to fraud and corruption allegations
Moderator
Inngeun Han General Counsel, Daewoo Information
Panelists
YooRee Kim General Counsel, Legal & Compliance Officer, Teva-Handok Pharmaceutical Co.
David Yongdae Lee Head of Anti-Bribery & Corruption ASP, Financial Crime Compliance, Asia Pacific, The Hongkong and Shanghai Banking Corporation Limited
YoungDo Kim Legal & Compliance Director, Medtronic Korea
Disclaimer: **** This electronic message transmission contains information from Thomson Reuters and is confidential and privileged. The information is intended to be for the use of the individual or entity named above. If you are not the intended recipient, be aware that any disclosure, copying,distribution, or use of the contents of this information is prohibited. Any offer of goods or services will be subject to Thomson Reuters terms and conditions available upon request. If you have received this electronic transmission in error, please notify us by telephone immediately on +65 6870 3431 ****
